No abstract

Diagnosis, management, and treatment of Dieulafoy’s lesion have been complicated since its first mention in 1884. With increased awareness over the decades, Dieulafoy’s lesions are being managed differently based on the physician’s expertise. Herein, we report a case of a 58-year-old female who was found to have a Dieulafoy’s lesion on endoscopy, with her treatment complicated by gastric necrosis and perforation after multiple embolizations and limited surgical resection.

Evidence implicates a role of advanced glycation end products (AGEs) in the development of atherosclerosis. The present study examined the relationship between plasma levels of AGEs and the clinical and angiographic characteristics of patients with symptomatic peripheral arterial disease (PAD). A total of 40 consecutive patients with symptomatic lower extremity PAD undergoing invasive evaluation were enrolled. Clinical history, angiographic data, and plasma levels of total AGE (tAGE), N?-carboxymethyllysine (CML), and high-sensitivity C-reactive protein were obtained. In multivariate analyses, there were independent relationships noted between tAGE levels and the presence of critical limb ischemia (CLI) (r 2?=?0.195, p?=?0.003), Rutherford stage (r 2?=?0.351, p?